Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
20
Mar |
Atritech Announces FDA Regulatory UpdateCategory: Cardiovascular / Cardiology | Leave a Comment |
Atritech, Inc., an emerging medical device company, announced that it has obtained clarity from the U.S. Food and Drug Agency (FDA) on the regulatory path towards full approval of its WATCHMAN® Left Atrial Appendage (LAA) Closure Technology in the United States…
GE Healthcare, the $17 billion medical technology division of General Electric Company (NYSE:GE), today announced the Mac-Lab’s validation of compatibility with the Volcano’s SmartMap® Pressure Instrument and PrimeWire® Pressure Guide Wire for evaluation of Fractional Flow Reserve (FFR)…
|
17
Mar |
GE’s Virtual Sleep Lab Enables Sleep Apnea Testing In Hospitalized Cardiac PatientsCategory: Cardiovascular / Cardiology | Leave a Comment |
GE Healthcare introduced MARS® Virtual Sleep Lab (VSL), the first device to provide a streamlined view of quantitative cardiac and sleep apnea analysis from any GE-monitored inpatient bed, helping enhance speed of diagnosis. MARS VSL is being featured at the American College of Cardiology (ACC) 59th Annual Scientific Session, held March 14 to 16 in Atlanta…
Boston Scientific Corporation (NYSE: BSX) announced 12-month results from its PERSEUS clinical program that demonstrated positive safety and efficacy outcomes in workhorse lesions for the platinum chromium TAXUS® Element™ Paclitaxel-Eluting Stent System compared to the TAXUS® Express2™ Paclitaxel-Eluting Stent System…
|
16
Mar |
Boston Scientific Announces Ship Hold And Inventory Retrieval Of ICD And CRT-D DevicesCategory: Cardiovascular / Cardiology | Leave a Comment |
Boston Scientific Corporation (NYSE: BSX) announced today that it has stopped shipment and is retrieving field inventory of all its implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The Company has determined that some manufacturing process changes were not submitted for approval to the U.S. Food and Drug Administration (FDA)…
|
16
Mar |
Toshiba Introduces New X-Ray System With 12″ X 12″ Flat Panels And Hybrid Catheterization Table At ACC 2010Category: Cardiovascular / Cardiology | Leave a Comment |
When working on patients in a hybrid setting, it is critical the imaging system provides outstanding image quality, as well as the flexibility to reach ancillary equipment and the patient quickly and easily. Designed to create a best-in-class hybrid suite, Toshiba America Medical Systems, Inc…
|
16
Mar |
Toshiba’s Cath Lab Used During Interventional Live Cases At ACC 2010Category: Cardiovascular / Cardiology | Leave a Comment |
In interventional procedures, it is critical that the imaging system provide outstanding image quality, as well as positioning flexibility for clinicians to access ancillary equipment and the patient quickly and easily. Toshiba America Medical Systems, Inc.’s InfinixTM-i cardiovascular X-ray systems, featuring the unique C-arm positioner, are specifically designed to excel in this setting…
|
15
Mar |
Safety And Efficacy Of Drug-Eluting Stents Vs. Bypass Surgery To Be Determined By EXCEL TrialCategory: Cardiovascular / Cardiology | Leave a Comment |
The announcement of a new clinical trial, EXCEL (Evaluation of Xience Prime versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization), that will compare drug-eluting stents to coronary artery bypass graft surgery in patients with left main coronary artery disease, was made today at “Optimizing PCI Outcomes: Evolving Paradigms,” a symposium presente…
|
14
Mar |
Medtronic Starts International Study Of CoreValve(R) Transcatheter Aortic Valve SystemCategory: Cardiovascular / Cardiology | Leave a Comment |
Moving to expand the evidence base for the future of structural heart disease therapy, Medtronic, Inc. (NYSE: MDT), announced the start of the first of several new initiatives in a robust international clinical program for its CoreValve transcatheter aortic valve system, a minimally-invasive alternative to open-heart surgery for aortic valve replacement…
|
12
Mar |
TAU On Track To Prevent “Sudden Cardiac Arrest”Category: Cardiovascular / Cardiology | Leave a Comment |
Sudden Cardiac Arrest syndrome (SCA) is poorly understood, but it’s a real danger for the otherwise young and healthy. For no apparent reason, the heart suddenly stops beating, and without treatment death may follow within minutes. It’s why some athletes drop dead on the track and why a young man, without any warning, suddenly dies while sitting at his desk…